Group to promote the use of recurrent data in clinical trials

Philip Hougaard (Deltager)

Epidemiologi, Biostatistik og Biodemografi (EBB)

Aktivitet: Andre aktiviteter › Andet

Beskrivelse

The group has submitted a qualification application to the EMA (European Medicines Agency) and the proposal is now open for public comments

Periode	2019

Relateret indhold

Publikationer
Draft qualification opinion of clinically interpretable treatment effect measures based on recurrent event endpoints that allow for efficient statistical analyses: Call for comments to EMA
Publikation: Bidrag til udredning/notat › Bidrag til faglig redegørelse